SARS-CoV-2 (SAR)

The SARS-CoV-2 Clinical Scheme (SAR) is the Proficiency Testing answer from AXIO to the Global COVID-19 pandemic.

Governments, health bodies, hospitals, virology labs, and indeed most of the world’s population find themselves locked in a war with the novel virusCOVID-19.  AXIO Proficiency Testing is now directly involved in COVID-19-related work, from supporting diagnostic kit manufacturers, diagnostic testing, and clinical research to providing quality assurance tools to ensure the reliability of measurements being made.

As increasing numbers of diagnostic methods are made available in the global fight against COVID-19, laboratories must ensure that their application of methods and subsequent results are reliable and accurate using external quality assurance tools, including proficiency testing. Test materials include swab and plasma samples, to meet all Clinical laboratories and Point of Care Testing requirements.